A detailed history of Davis Investment Partners, LLC transactions in Incyte Corp stock. As of the latest transaction made, Davis Investment Partners, LLC holds 17,737 shares of INCY stock, worth $1.2 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
17,737
Previous 11,913 48.89%
Holding current value
$1.2 Million
Previous $655 Million 72.33%
% of portfolio
0.46%
Previous 0.29%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

BUY
$51.18 - $63.75 $298,072 - $371,280
5,824 Added 48.89%
17,737 $1.13 Billion
Q1 2024

Apr 15, 2024

SELL
$56.55 - $66.59 $51,064 - $60,130
-903 Reduced 7.05%
11,913 $655 Million
Q4 2023

Jan 12, 2024

BUY
$52.16 - $64.19 $20,133 - $24,777
386 Added 3.11%
12,816 $853 Million
Q3 2023

Oct 10, 2023

BUY
$57.77 - $65.93 $751 - $857
13 Added 0.1%
12,430 $731 Million
Q2 2023

Aug 01, 2023

SELL
$60.95 - $75.51 $72,042 - $89,252
-1,182 Reduced 8.69%
12,417 $795 Million
Q1 2023

Apr 14, 2023

SELL
$70.23 - $86.01 $27,389 - $33,543
-390 Reduced 2.79%
13,599 $988 Million
Q4 2022

Feb 14, 2023

BUY
$67.18 - $84.11 $939,781 - $1.18 Million
13,989 New
13,989 $1.12 Billion

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Davis Investment Partners, LLC Portfolio

Follow Davis Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Davis Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davis Investment Partners, LLC with notifications on news.